Supply Chain Intelligence

Precision BioSciences, Inc. Supply Chain

DTIL supply chain intelligence for Precision BioSciences, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

DTIL ·Last updated 2026-07-29 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

6Suppliers
9Customers
3Debt Items
20Related Chains

Precision BioSciences, Inc. Suppliers

TickerNameConfidenceEvidence
MXCT MaxCyte, Inc. 85% Reciprocal relationship from MXCT graph: ory approval for all or any product candidates covered by their SPL agreements with us, in which case we will not receive the full potential precommercial mil…
CRBU Caribou Biosciences, Inc. 72% Reciprocal relationship from CRBU graph: untries where our product candidates may be sold at lower prices than in the United States. Third-party payors, whether domestic or foreign, governmental or c…
MGX Metagenomi Therapeutics, Inc. 72% Reciprocal relationship from MGX graph: Reciprocal relationship from DTIL graph: Reciprocal relationship from MGX graph: Reciprocal relationship from DTIL graph: Reciprocal relationship from MGX grap…
PRME Prime Medicine, Inc. 72% Reciprocal relationship from PRME graph: Reciprocal relationship from DTIL graph: Reciprocal relationship from PRME graph: tic effect in such experiments or studies or they may have other characteris…
TGTX TG Therapeutics, Inc. 72% Reciprocal relationship from TGTX graph: oduct candidates. The Company may seek significant additional financing in the future to support strategic initiatives and its ongoing and planned operations.…
IECURE-INC IECURE-INC 60% The Company adjusts the carrying value of the iECURE, Inc. equity to fair value each reporting period

Precision BioSciences, Inc. Customers

TickerNameConfidenceEvidence
TG-THERAPEUTICS TG-THERAPEUTICS 90% Under the TG License Agreement, the Company received an upfront cash payment of $ 10.0 million
AGRICULTURE-INDUSTRY-COLLABORATION-PARTNER AGRICULTURE-INDUSTRY-COLLABORATION-PARTNER 80% The Company recognized $ 4.0 million in revenue under a legacy ARCUS gene editing research and license agreement milestone from an agriculture industry collaboration partner
SERVIER SERVIER 80% The Program Purchase Agreement requires the Company to make certain payments to Servier based on the achievement of regulatory and commercial milestones for each product
CRBU Caribou Biosciences, Inc. 72% Reciprocal relationship from CRBU graph: Reciprocal relationship from DTIL graph: Reciprocal relationship from CRBU graph: Reciprocal relationship from DTIL graph: Reciprocal relationship from CRBU g…
MGX Metagenomi Therapeutics, Inc. 72% Reciprocal relationship from MGX graph: amples of any lot of any approved product together with the protocols showing the results of applicable tests at any time. Under some circumstances, the FDA, t…
MXCT MaxCyte, Inc. 72% Reciprocal relationship from MXCT graph: ory approval for all or any product candidates covered by their SPL agreements with us, in which case we will not receive the full potential precommercial mil…
PRME Prime Medicine, Inc. 72% Reciprocal relationship from PRME graph: Reciprocal relationship from DTIL graph: Reciprocal relationship from PRME graph: Reciprocal relationship from DTIL graph: Reciprocal relationship from PRME g…
TGTX TG Therapeutics, Inc. 72% Reciprocal relationship from TGTX graph: oduct candidates. The Company may seek significant additional financing in the future to support strategic initiatives and its ongoing and planned operations.…
NOVARTIS-PHARMA-AG NOVARTIS-PHARMA-AG 70% The Company recognized revenue under the Novartis Agreement of less than $ 0.1 million

Precision BioSciences, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
DTIL-DEBT-9166 Warrants outstanding: 11129000 90% xbrl warrant detail from xbrl 2025-12-31.
DTIL-DEBT Debt stack $28.5M 90% Market cache reports total debt of $28.5M.
DTIL-DEBT-9167 Xbrl Convertible 90% xbrl convertible detail from xbrl 2019-12-31.

Precision BioSciences, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Precision BioSciences, Inc..

Precision BioSciences, Inc. Ownership

HolderNameConfidenceEvidence
DTIL-OWNER-OCTAGON-CAPITAL-ADVISORS-LP Octagon Capital Advisors LP 90% 13F overlay lists Octagon Capital Advisors LP as top holder; 78 tracked holders.

Precision BioSciences, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ARMK Aramark 100.00 2
BSAC Banco Santander-Chile 100.00 2
ARM Arm Holdings plc 100.00 2
BRBS Blue Ridge Bankshares, Inc. 100.00 2
CHYM Chime Financial, Inc. 100.00 2
BLX Banco Latinoamericano de Comercio Exterior, S. A. 100.00 2
AUTL Autolus Therapeutics plc 100.00 2
FNWB First Northwest Bancorp 100.00 2
BTTC Black Titan Corporation 100.00 2
VRNO Verano Holdings Corp. 100.00 2
CRBU Caribou Biosciences, Inc. 100.00 2 ['customer', 'supplier']
BSBR Banco Santander (Brasil) S.A. 100.00 2
GEMI Gemini Space Station, Inc. 100.00 2
BRBI BRBI BR Partners S.A. 100.00 2
CNF CNFinance Holdings Limited 100.00 2
BMA Banco Macro S.A. 100.00 2
AVAL Grupo Aval Acciones y Valores S.A. 100.00 2
BBAR Banco BBVA Argentina S.A. 100.00 2
ENLT Enlight Renewable Energy Ltd 100.00 2
BCH Banco de Chile 100.00 2
View DTIL supply chain intel →

Explore the full interactive supply chain map for Precision BioSciences, Inc..

Open DTIL supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map